Treating muscle wasting with selective androgen receptor modulators

Details for Australian Patent Application No. 2002364949 (hide)

Owner GTX, Inc.

Inventors Steiner, Mitchell S; Dalton, James T; Miller, Duane D; Veverka, Karen A

Agent Griffith Hack

Pub. Number AU-B-2002364949

PCT Number PCT/US02/36147

PCT Pub. Number WO2003/049675

Priority 60/336,185 06.12.01 US

Filing date 5 December 2002

Wipo publication date 23 June 2003

Acceptance publication date 22 February 2007

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/00 (2006.01)

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/275 (2006.01) - Nitriles

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 39/02 (2006.01) General protective or antinoxious agents

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/336,185 06.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002364949

22 February 2007 Application Accepted

  Published as AU-B-2002364949

21 June 2007 Standard Patent Sealed

29 May 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 25 Jul 2007 2003

18 March 2010 Assignment Registered

  GTX, Inc. The patent has been assigned to University of Tennessee Research Foundation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002364950-BETA-CYCLODEXTRIN DIMERS AND PHTHALOCYANINES AND USES THEREOF

2002364948-CRYSTALS AND STRUCTURES OF MEMBERS OF THE E. COLI COMA AND YDDB PROTEIN FAMILIES (COMA)